# Baclofen for Children With Rumination Syndrome

> **NCT05975684** · PHASE3 · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 50 (actual)

## Conditions studied

- Rumination Syndrome

## Interventions

- **DRUG:** Baclofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05975684
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-31
- **Primary completion:** 2024-07-31
- **Final completion:** 2025-01-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05975684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05975684, "Baclofen for Children With Rumination Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05975684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
